发明名称 Benzamide formulation with histone deacetylase inhibitor activity
摘要 There are provided pharmaceutical formulations with improved oral absorptivity and injections that contain, as active ingredients, high concentrations of benzamide derivatives and their pharmaceutically acceptable salts, which are useful as histone deacetylase inhibitors.A pharmaceutical solution is prepared by dissolving a benzamide derivative or a pharmaceutically acceptable salt thereof in an organic solvent and/or acidic liquid, and a pharmaceutical formulation is prepared by adding a surfactant, an acidic substance and/or a polyethylene glycol.The present invention has enabled dissolution of benzamide derivatives or their pharmaceutically acceptable salts at high concentrations, to prepare practical injections and oral liquid formulations and improve absorptivity with oral administration.
申请公布号 US6638530(B1) 申请公布日期 2003.10.28
申请号 US20020069582 申请日期 2002.02.27
申请人 SCHERING AKTIENGESELLSCHAFT 发明人 ISHIBASHI MASAHIKO;SAKABE MASAHIRO;SAKAI IKUO;SUZUKI TSUNEJI;ANDO TOMOYUKI
分类号 A61K47/00;A61K9/08;A61K9/20;A61K9/48;A61K9/66;A61K31/4406;A61K31/4418;A61K47/04;A61K47/10;A61K47/12;A61K47/16;A61K47/18;A61K47/20;A61K47/22;A61K47/26;A61K47/34;A61K47/36;A61K48/00;A61P35/00;A61P37/06;A61P43/00;C07D213/30;C07D213/65;C07D213/75;(IPC1-7):A61K9/66;A61K31/44 主分类号 A61K47/00
代理机构 代理人
主权项
地址